Geode Capital Management
TLOG

Geode Capital Management’s TetraLogic Pharmaceuticals Corporation TLOG Stock Holding History

Geode Capital Management’s Portfolio TLOG Stock Details TLOG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-76,763
Closed -$12K – 4100
2016
Q3 		$12K Buy
76,763
+85
+0.1% +$20 ﹤0.01% 4014
2016
Q2 		$23K Hold
76,678
– – ﹤0.01% 4017
2016
Q1 		$13 Sell
76,678
-85
-0.1% -$24 ﹤0.01% 4079
2015
Q4 		$132K Buy
76,763
+170
+0.2% +$299 ﹤0.01% 3816
2015
Q3 		$143K Buy
76,593
+170
+0.2% +$404 ﹤0.01% 3792
2015
Q2 		$178K Buy
76,423
+33,487
+78% +$103K ﹤0.01% 3622
2015
Q1 		$188K Buy
42,936
+10,407
+32% +$52.2K ﹤0.01% 3605
2014
Q4 		$156K Buy
32,529
+255
+0.8% +$1.14K ﹤0.01% 3674
2014
Q3 		$134K Buy
32,274
+170
+0.5% +$792 ﹤0.01% 3685
2014
Q2 		$189K Sell
32,104
-2,060
-6% -$11.7K ﹤0.01% 3532
2014
Q1 		$217K Buy
+34,164
New +$308K ﹤0.01% 3470

Other funds holding TLOG

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
BWA
Burt Wealth Advisors North Bethesda, Maryland $407M AUM 11.98% 1-Year Est. Return

Geode Capital Management's TLOG Position: Q4 2016 in Review

Geode Capital Management sold out of TetraLogic Pharmaceuticals Corporation (TLOG) in Q4 2016, closing a stake of 76,763 shares — an estimated $12K sold.

Geode Capital Management first reported a position in TLOG in Q1 2014 and held it in 11 quarters. The position peaked at $217K in Q1 2014. 3 funds tracked by Wall St. Rank hold TLOG as of Q4 2016.

  • Geode Capital Management reported no remaining TetraLogic Pharmaceuticals Corporation position as of Q4 2016 after selling out during the quarter.
  • Geode Capital Management sold 76,763 TetraLogic Pharmaceuticals Corporation shares in Q4 2016, an estimated $12K.
  • Geode Capital Management first reported a position in TetraLogic Pharmaceuticals Corporation in Q1 2014 and held it in 11 quarters.
  • Geode Capital Management's TetraLogic Pharmaceuticals Corporation position peaked at $217K in Q1 2014.
  • 3 funds tracked by Wall St. Rank held TetraLogic Pharmaceuticals Corporation as of Q4 2016.

Based on Geode Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.